Advertisement
U.S. Markets closed

AtriCure, Inc. (ATRC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
27.93-0.75 (-2.62%)
At close: 04:00PM EDT
27.93 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close28.68
Open28.67
Bid0.00 x 0
Ask0.00 x 0
Day's Range27.64 - 28.90
52 Week Range18.94 - 43.00
Volume559,837
Avg. Volume614,504
Market Cap1.405B
Beta (5Y Monthly)1.44
PE Ratio (TTM)N/A
EPS (TTM)-0.86
Earnings DateOct 29, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est38.43
  • Zacks

    AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device

    ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks.

  • Business Wire

    AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management

    MASON, Ohio, October 15, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE MAX™ cryoablation probe. The cryoSPHERE MAX probe features a larger ball tip designed to optimize Cryo Nerve Block™ therapy (cryoNB). The new probe reduces freeze times by 50% when compared to AtriCure’s first generation